問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

林聖堯Lin, Sheng Yiao
  • Principal Investigator
  • Clinical Trial Experience (year) 7 years 9 個月

篩選

List

13Cases

2021-04-30 - 2025-09-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites

2019-04-01 - 2022-06-20

Phase III

A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
  • Condition/Disease

    Atopic Dermatitis

  • Test Drug

    Lebrikizumab

Participate Sites
7Sites

Recruiting7Sites

1 2